Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-06-24 2021-07-15 141463
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-08-27 2021-09-23 144726
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-09-16 2022-04-21 145780
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-06-09 2022-06-17 162283
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2022-12-15 176776
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-09-05 2024-09-19 236802
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-12-13 2025-03-13 245601
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-01-16 2025-02-13 247885
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-06 2025-04-24 252075
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-27 2025-04-10 253568
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-05-08 2025-10-02 256917
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-23 2025-11-27 270218
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-30 2025-11-27 270660
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2022-08-18 2022-12-22 167237
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-08 2023-07-05 194180

Showing 641 to 660 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LAMOTRIGINE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258646
TEVA-LAMOTRIGINE 150MG TABLET Discontinued 2025-05-28 2025-05-28 258652
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-25 2025-04-25 255824
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-04-29 2025-04-29 256085
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258507
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Discontinued 2025-05-28 2025-05-28 258510
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LEVOCARBIDOPA 25MG 250MG TABLET Discontinued 2025-05-28 2025-05-28 258625
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL (TYPE Z) 20MG TABLET Discontinued 2025-05-28 2025-05-28 258694
TEVA-LISINOPRIL (TYPE Z) 5MG TABLET Discontinued 2025-05-28 2025-05-28 258699
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368

Showing 261 to 280 of 435